
Max Healthcare’s 800% rally hits a wall: Is a 74x P/E ratio sustainable in 2026?
In 2025, Max Healthcare’s share price plateaued after an 800% rally as the company’s ROCE and EBITDA margins fell with new capacity addition. At a 74x P/E ratio, is there more upside for the stock in 2026?




